Telix Pharmaceuticals income statement data for the quarter ended Jun 2026. This income statement covers 4 quarters of results from Dec 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2023 | Dec2024 | Dec2025 | Jun2026 |
|---|---|---|---|---|
| Additional items | ||||
| Shares Outstanding | 319.18M | 331.23M | 337.88M | 337.88M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 323.71M | 345.19M | 337.88M | 337.88M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 323.73M | 334.72M | 338.78M |
Pull Telix Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=TLX&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "TLX", "statement": "IS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=TLX&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();